论文已发表
提 交 论 文
注册即可获取Ebpay生命的最新动态
注 册
IF 收录期刊
2 型糖尿病患者药物自我管理的影响因素与障碍:基于 COM-B 模型的定性研究
Authors Li H, Li Y, Wang J, Zhang Y, Ben S
Received 28 October 2024
Accepted for publication 18 February 2025
Published 1 March 2025 Volume 2025:19 Pages 485—501
DOI http://doi.org/10.2147/PPA.S503350
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Jongwha Chang
Huiqin Li,1 Ying Li,2,* Jing Wang,3,* Yuyao Zhang,1 Shiyan Ben1
1School of Nursing, Anhui University of Chinese Medicine, Hefei, People’s Republic of China; 2Clinical Pharmacy, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, People’s Republic of China; 3Department of Endocrinology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Ying Li, Jing Wang; The First Affiliated Hospital of Anhui University of Chinese Medicine, No. 117 Meishan Road, Hefei, Anhui, People’s Republic of China, Tel +86-189-1961-4050, +86-138-6619-2906, Email 1807883959@qq.com, 800wjj@163.com
Introduction: Type 2 diabetes mellitus is a chronic disease of global concern. Medication self-management is the process by which an individual actively plans, monitors, evaluates, feeds back, controls, and regulates their medication through their behavior and awareness. Patients’ medication self-management is key to glycemic control. A comprehensive understanding of the factors influencing medication self-management and the implementation of effective intervention programs is therefore paramount.
Objective: To examine the enablers and barriers to medication self-management in patients with type 2 diabetes mellitus and to propose a corresponding medication self-management program to improve medication self-management.
Methods: This qualitative study drew up the interview outline with reference to the COM-B model. Sampling was done using purposive sampling method and data collection was done using semi-structured interviews. The interviews mainly included patients’ challenges and facilitators in the process of medication self-management. The data were analyzed using a framework analysis method, and themes were generated using the COM-B model.
Results: A total of 20 patients participated in this study. The enablers identified within the COM-B model were the policy support for medical insurance and higher medication self-efficacy. The barriers include low medication literacy, aging of body functions, changes in living habits, the impact of work, limited medical resources, misguided beliefs about medication, and emotional response. The online media applications and the impact of family and friends were mixed factors. Outside of the model, diet and exercise also have an impact. Finally, we propose targeted solutions to improve medication self-management based on the Behavior Change Wheel.
Conclusion: This study proposes targeted medication self-management programs, including education interventions to improve medication literacy and self-efficacy, leveraging smart devices, and improving health insurance policies to promote patient medication management levels. Our findings will contribute to medication self-management for type 2 diabetes and many more chronic diseases.
Keywords: type 2 diabetes mellitus, medication self-management, enablers, barriers, qualitative study, framework analysis